Stimulates T-lymphocyte differentiation and humoral immunity in elderly and immunocompromised patients.
Reference facts
- Also known as
- Thymus extract polypeptide complex
- Category
- Khavinson Bioregulators
- Mechanism of action
- Stimulates T-lymphocyte differentiation and humoral immunity in elderly and immunocompromised patients.
- Targets
- T-cell differentiation
- Indications under research or approved
- Approved Russia (immunodeficiency); not US-approved
- Regulatory status (reference entry)
- Not FDA-approved
- Half-life
- Variable (mixture)
- Sequence notes
- Polypeptide mixture extracted from calf thymus, used in Russia and Ukraine as immunomodulator.
- First reported
- 1981
Primary References
Explore research articles about Thymalin
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.